Ernst et al. showed that NPM1 mutations occurred in 6/187 (3%) MDS/MPN patients and the 6 patients were all CMML patients, indicating that NPM1 mutation may be associated with a poor prognosis [34]. The gene discussed is NPM1; the disease is chronic myelomonocytic leukemia.